Publications by authors named "Elliott B Nickbarg"

Claim this Profile
P
Pharmacological validation of dihydrofolate reductase as a drug target in .
Wassihun Wedajo Aragaw, Dereje A Negatu, Christopher J Bungard, Véronique A Dartois, Abdellatif El Marrouni, Elliott B Nickbarg

Antimicrob Agents Chemother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RNA with small molecules: lessons learned from Xist RNA.
Elliott B Nickbarg, Kerrie B Spencer, Jonathan D Mortison, Jeannie T Lee

RNA· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Xist with compounds that disrupt RNA structure and X inactivation.
Rodrigo Aguilar, Kerrie B Spencer, Barry Kesner, Noreen F Rizvi, Maulik D Badmalia, Elliott B Nickbarg

Nature· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors.
Wensheng Yu, Yongqi Deng, Brett Hopkins, Xianhai Huang, David Sloman, Elliott B Nickbarg

Bioorg Med Chem Lett· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbamate and -Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors.
Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett Andrew Hopkins, Elliott B Nickbarg

ACS Med Chem Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space.
Noreen F Rizvi, John P Santa Maria, Ali Nahvi, Joel Klappenbach, Daniel J Klein, Elliott B Nickbarg

SLAS Discov· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1).
Catherine White, Meredeth A McGowan, Hua Zhou, Nunzio Sciammetta, Xavier Fradera, Elliott B Nickbarg

ACS Med Chem Lett· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry.
Noreen F Rizvi, Elliott B Nickbarg

Methods· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry.
Deborah A Flusberg, Noreen F Rizvi, Victoria Kutilek, Christine Andrews, Peter Saradjian, Elliott B Nickbarg

SLAS Discov· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry.
Noreen F Rizvi, John A Howe, Ali Nahvi, Daniel J Klein, Thierry O Fischmann, Elliott B Nickbarg

ACS Chem Biol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway.
Victoria D Kutilek, Christine L Andrews, Matthew P Richards, Zangwei Xu, Tianxiao Sun, Elliott B Nickbarg

J Biomol Screen· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis